Latest News On Clinical Trials

Latest KFF Health News Stories

Trump Administration Is Ending Multiple HIV Vaccine Studies, Scientists and Officials Say

KFF Health News Original

The cuts will shutter two major HIV vaccine research efforts, and a National Institutes of Health senior official said the agency has been instructed not to issue any more HIV vaccine research funding in the next fiscal year, with few exceptions.

Empresas de capital riesgo invierten en el negocio de los ensayos clínicos de medicamentos. ¿Cuál es el riesgo para los pacientes?

KFF Health News Original

Para lanzar un nuevo fármaco al mercado, la Administración de Alimentos y Medicamentos (FDA) exige a las farmacéuticas estudios exhaustivos para demostrar su seguridad y eficacia. Conseguir que un medicamento salga al mercado unos meses antes, y con menos gastos de lo habitual, puede traducirse en beneficios millonarios para el fabricante.

Why Cheap, Older Drugs That Might Treat Covid Never Get Out of the Lab

KFF Health News Original

The hydroxychloroquine and ivermectin fiascoes have soured many doctors on repurposing drugs for covid. A few inexpensive old drugs may be as good as some of the new antivirals, but they face complex obstacles to get to patients.

Which Companies Aren’t Exiting Russia? Big Pharma

KFF Health News Original

U.S. and global drug manufacturers invested in Russia’s sizable pharmaceutical industry contend international humanitarian law requires they continue manufacturing and selling their products there, even while condemning the Ukraine invasion. Not everyone agrees.

Patients Divided Over Alzheimer’s Drug: Is It a ‘Risk I’m Willing to Take’ or Just a ‘Magic Pill’?

KFF Health News Original

Medicare has proposed limiting coverage of Aduhelm, the costly new drug to treat Alzheimer’s disease, and several prominent groups representing patients and their families are pressing the program to make it more widely available. But among individuals facing the disease, the outlook is more nuanced.

Dying Patients With Rare Diseases Struggle to Get Experimental Therapies

KFF Health News Original

When patients with common terminal illnesses such as cancer seek permission for compassionate use of therapies in the testing stage, their requests often are approved. But those with more unusual illnesses say drug companies are rarely willing to provide access.

These Secret Safety Panels Will Pick the COVID Vaccine Winners

KFF Health News Original

Data and safety monitoring boards work under a cloak of secrecy meant to prevent undue influence by stakeholders, such as companies or the government. In the Trump era, some worry the anonymity could actually invite it.

Dozens of U.S. Hospitals Poised to Defy FDA’s Directive on COVID Plasma

KFF Health News Original

The FDA, under pressure from the Trump administration, has authorized broader use of convalescent plasma for emergency treatment in COVID patients. But several major hospitals are resisting, saying they’ll opt instead to use the scarce resource to complete a clinical trial.

5 Things to Know About Convalescent Blood Plasma

KFF Health News Original

President Donald Trump touted the Food and Drug Administration’s approval of this unproven COVID-19 treatment for emergency use. That set off reactions ranging from excitement and optimism to scientific concerns and criticism that the decision was politically motivated.